425 related articles for article (PubMed ID: 2471812)
1. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
[TBL] [Abstract][Full Text] [Related]
2. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites.
Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F; Parry NR
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1483-91. PubMed ID: 2471811
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.
Xie QC; McCahon D; Crowther JR; Belsham GJ; McCullough KC
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1637-47. PubMed ID: 2438378
[TBL] [Abstract][Full Text] [Related]
5. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.
Meloen RH; Puyk WC; Meijer DJ; Lankhof H; Posthumus WP; Schaaper WM
J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606
[TBL] [Abstract][Full Text] [Related]
6. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
Stave JW; Card JL; Morgan DO
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
[TBL] [Abstract][Full Text] [Related]
8. A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles.
Parry NR; Syred A; Rowlands DJ; Brown F
Immunology; 1988 Aug; 64(4):567-72. PubMed ID: 2844657
[TBL] [Abstract][Full Text] [Related]
9. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI.
Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D
J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800
[TBL] [Abstract][Full Text] [Related]
10. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
[TBL] [Abstract][Full Text] [Related]
11. Host cell selection of antigenic variants of foot-and-mouth disease virus.
Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
[TBL] [Abstract][Full Text] [Related]
12. [Synthetic peptides simulating the protective epitopes of VP1 protein of foot-and-mouth disease virus type O and A].
Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN
Bioorg Khim; 1987 Aug; 13(8):1132-5. PubMed ID: 2445357
[TBL] [Abstract][Full Text] [Related]
13. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease.
Mateu MG; Rocha E; Vicente O; Vayreda F; Navalpotro C; Andreu D; Pedroso E; Giralt E; Enjuanes L; Domingo E
Virus Res; 1987 Sep; 8(3):261-74. PubMed ID: 2446442
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
[TBL] [Abstract][Full Text] [Related]
15. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants.
McCahon D; Crowther JR; Belsham GJ; Kitson JD; Duchesne M; Have P; Meloen RH; Morgan DO; De Simone F
J Gen Virol; 1989 Mar; 70 ( Pt 3)():639-45. PubMed ID: 2471793
[TBL] [Abstract][Full Text] [Related]
16. Analysis of neutralizing epitopes on foot-and-mouth disease virus.
Pfaff E; Thiel HJ; Beck E; Strohmaier K; Schaller H
J Virol; 1988 Jun; 62(6):2033-40. PubMed ID: 2835507
[TBL] [Abstract][Full Text] [Related]
17. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
[TBL] [Abstract][Full Text] [Related]
18. Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay.
Diez J; Mateu MG; Domingo E
J Gen Virol; 1989 Dec; 70 ( Pt 12)():3281-9. PubMed ID: 2481712
[TBL] [Abstract][Full Text] [Related]
19. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12.
Robertson BH; Morgan DO; Moore DM
Virus Res; 1984 Sep; 1(6):489-500. PubMed ID: 6085200
[TBL] [Abstract][Full Text] [Related]
20. Foot-and-mouth disease and its antigens.
Bachrach HL
Adv Exp Med Biol; 1985; 185():27-46. PubMed ID: 2416203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
